Pharmacokinetics of radioactively labeled glisoxepide in the animal
Kolb, K.H.; Schulze, P.E.; Speck, U.; Acksteiner, B.
Arzneimittel-Forschung 24: 397-403
1974
ISSN/ISBN: 0004-4172 PMID: 4211553 Document Number: 75004
Document emailed within 1 workday
Related Documents
Speck, U.; Mützel, W.; Kolb, K.H.; Acksteiner, B.; Schulze, P.E. 1974: Pharmacokinetics and metabolite spectrum of glisoxepide in humans Arzneimittel-Forschung 24: 404-409Heilmann, P.; Müller, G.; Finsterbusch, L. 1988: Lobar deposition of radioactively-labeled Pasteurella multocida aerosols in the lungs of piglets and calves Archiv für Experimentelle Veterinarmedizin 42(4): 490-501
Ruff, E.; Rizzino, A. 1986: Preparation and binding of radioactively labeled porcine transforming growth factor type beta Biochemical and Biophysical Research Communications 138(2): 714-719
Muller, H.J.; Lanens, D.; de Cock Buning, T.J.; van de Vyver, F.L.; Alderweireldt, F.C.; Dommisse, R.; Spanoghe, M.; Mulder, G.J.; Lugtenburg, J. 1992: Noninvasive in vivo 13C-NMR spectroscopy in the rat to study the pharmacokinetics of 13C-labeled xenobiotics Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(4): 507-509
Severin, S.E.; Kulakov, V.N.; Moskaleva, E.I.; Severin, E.S.; Slobodianik, I.I.; Klimova, T.P. 2012: The distribution of iodine-125 labeled alpha-fetoprotein in the animal organism and its accumulation in the tumor Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 4: 11-15
Zimmer, A.M.; Kazikiewicz, J.M.; Rosen, S.T.; Spies, S.M. 1987: Pharmacokinetics of 99mTc(Sn)- and 131I-labeled anti-carcinoembryonic antigen monoclonal antibody fragments in nude mice Cancer Research 47(6): 1691-1694
Kang, Y.S.; Boado, R.J.; Pardridge, W.M. 1995: Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(1): 55-59
Dengler, H.G.; Hengstmann, J.H. 1976: Metabolism and pharmacokinetics of orciprenaline in various animal species and man Archives Internationales de Pharmacodynamie et de Therapie 223(1): 71-87
Nakamura, A.; Sugihara, K.; Hirota, T.; Morino, A.; Ezumi, Y.; Takaichi, M. 1997: Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs Arzneimittel-Forschung 47(2): 151-159
Girometta, M.A.; Jauch, R.; Ponelle, C.; Guenzi, A.; Wiegand-Chou, R.C. 1994: Animal pharmacokinetics and metabolism of the new antimalarial Ro 42-1611 (arteflene) Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 45(3): 272-277
Markwardt, F.; Hauptmann, J.; Richter, M.; Richter, P. 1979: Animal experiments on the pharmacokinetics of 4-amidinophenylpyruvic acid (APPA) Die Pharmazie 34(3): 178-181
Cui, H. 1990: Biodistribution, pharmacokinetics and imaging of 131I-labeled HMD4 human McAb in human ovarian carcinoma xenograft in nude mice Zhonghua Fu Chan Ke Za Zhi 25(2): 80
Kietselaer, B.L.J.H.; Hofstra, L.; Dumont, E.A.W.; Reutelingsperger, C.P.M.; Heidendal, G.A.K. 2003: The role of labeled Annexin A5 in imaging of programmed cell death. From animal to clinical imaging Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 47(4): 349-361
Bopp, S.; Marre, R.; Schulz, E.; Sack, K. 1981: Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin Arzneimittel-Forschung 31(3): 473-477
Petzoldt, R.; Riedesel, G.; Ramrath, M.; Grabs, V.; Haupt, E.; Schwedes, U.; Ewald, W.; Beyer, J.; Schöffling, K. 1974: Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide Arzneimittel-Forschung 24: 429-432
Randzio, J.; Thoma, K.; Alex, R.; Rhomberg, B. 1985: Healing and pharmacokinetics of a beta-tricalcium phosphate-gentamycin combination in animal studies (preliminary report) Deutsche Zahnarztliche Zeitschrift 40(6): 668-671
Tanswell, P.; Heinzel, G.; Greischel, A.; Krause, J. 1990: Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver Journal of Pharmacology and Experimental Therapeutics 255(1): 318-324
Hauptmann, J.; Markwardt, F.; Richter, M. 1982: Animal experiments on the pharmacokinetics of N alpha-tosyl-(3-amidinophenyl)alanine piperidide (TAPAP), a new thrombin inhibitor Die Pharmazie 37(6): 430-433
Knapp, F.F.; Kropp, J.; Franken, P.R.; Visser, F.C.; Sloof, G.W.; Eisenhut, M.; Yamamichi, Y.; Shirakami, Y.; Kusuoka, H.; Nishimura, T. 1996: Pharmacokinetics of radioiodinated fatty acid myocardial imaging agents in animal models and human studies Quarterly Journal of Nuclear Medicine: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology 40(3): 252-269
Hörnchen, U.; Schüttler, J.; Stoeckel, H.; Eichelkraut, W. 1988: Pharmacokinetics and dynamics of endogenously released and therapeutically administered adrenaline in resuscitation. A comparative animal experimental study Der Anaesthesist 37(10): 615-619